Bosh sahifaSOBI • STO
add
Swedish Orphan Biovitrum AB (publ)
Yopilish kursi
268,00 kr
Kunlik diapazon
269,20 kr - 276,00 kr
Yillik diapazon
241,80 kr - 354,40 kr
Bozor kapitalizatsiyasi
96,43 mlrd SEK
Oʻrtacha hajm
260,50 ming
Narx/foyda
21,42
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
CNBC
17 soat oldin
S&P 500 fights for another record — plus, Eaton signals big data center opportunity
0,048%
1,62%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 6,18 mlrd | 13,47% |
Joriy xarajat | 3,53 mlrd | 0,28% |
Sof foyda | 636,00 mln | 183,93% |
Sof foyda marjasi | 10,30 | 150,00% |
Har bir ulushga tushum | 2,36 | 227,78% |
EBITDA | 2,14 mlrd | 37,10% |
Amaldagi soliq stavkasi | 20,15% | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,06 mlrd | 35,82% |
Jami aktivlari | 68,75 mlrd | -6,04% |
Jami passivlari | 29,68 mlrd | -19,38% |
Umumiy kapital | 39,07 mlrd | — |
Tarqatilgan aksiyalar | 344,61 mln | — |
Narxi/balansdagi bahosi | 2,36 | — |
Aktivlardan daromad | 4,49% | — |
Kapitaldan daromad | 5,94% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 636,00 mln | 183,93% |
Operatsiyalardan naqd pul | 1,45 mlrd | -37,83% |
Sarmoyadan naqd pul | -424,00 mln | -863,64% |
Moliyadan naqd pul | -988,00 mln | 51,62% |
Naqd pulning sof oʻzgarishi | 61,00 mln | -75,79% |
Boʻsh pul | 888,38 mln | -60,42% |
Haqida
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Tashkil etilgan
1939
Sayt
Xodimlar soni
1 937
